المؤلفون: Yu YK; Section of Esophageal and Mediastinal Oncology, Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan Province, China., Meng FY; Department of Thoracic Surgery, The First Hospital of Jilin University, Changchun, Jilin Province, China., Wei XF; Section of Esophageal and Mediastinal Oncology, Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Chen XK; Section of Esophageal and Mediastinal Oncology, Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Li HM; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan Province, China., Liu Q; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan Province, China., Li CJ; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China., Xie HN; Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China., Xu L; Section of Esophageal and Mediastinal Oncology, Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Department of Thoracic Surgery, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China., Zhang RX; Section of Esophageal and Mediastinal Oncology, Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Xing W; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan Province, China. Electronic address: xingwenqun@sina.com., Li Y; Section of Esophageal and Mediastinal Oncology, Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Electronic address: liyin_thorax@163.com.

المصدر: The Journal of thoracic and cardiovascular surgery [J Thorac Cardiovasc Surg] 2024 Aug; Vol. 168 (2), pp. 417-428.e3. Date of Electronic Publication: 2024 Jan 19.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 0376343 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-685X (Electronic) Linking ISSN: 00225223 NLM ISO Abbreviation: J Thorac Cardiovasc Surg Subsets: MEDLINE

مواضيع طبية MeSH: Esophageal Squamous Cell Carcinoma*/therapy , Esophageal Squamous Cell Carcinoma*/mortality , Esophageal Squamous Cell Carcinoma*/pathology , Esophageal Neoplasms*/therapy , Esophageal Neoplasms*/mortality , Esophageal Neoplasms*/pathology , Neoadjuvant Therapy*/mortality , Neoadjuvant Therapy*/adverse effects, Humans ; Male ; Female ; Middle Aged ; Aged ; Retrospective Studies ; Esophagectomy/mortality ; Esophagectomy/adverse effects ; Immunotherapy/methods ; Chemoradiotherapy, Adjuvant/mortality ; Chemoradiotherapy, Adjuvant/adverse effects ; Chemotherapy, Adjuvant ; Treatment Outcome ; Disease-Free Survival ; Chemoradiotherapy/mortality

المؤلفون: Xiao C; Cancer Prevention and Treatment Institute of Chengdu, Department of Thyroid and Breast Surgery, Chengdu Fifth People's Hospital (Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine), NO.33 Ma Shi Street, Wenjiang District, Chengdu, 611137, China., Guo Y; Cancer Prevention and Treatment Institute of Chengdu, Department of Thyroid and Breast Surgery, Chengdu Fifth People's Hospital (Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine), NO.33 Ma Shi Street, Wenjiang District, Chengdu, 611137, China., Xu Y; Cancer Prevention and Treatment Institute of Chengdu, Department of Thyroid and Breast Surgery, Chengdu Fifth People's Hospital (Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine), NO.33 Ma Shi Street, Wenjiang District, Chengdu, 611137, China., Huang J; Cancer Prevention and Treatment Institute of Chengdu, Department of Thyroid and Breast Surgery, Chengdu Fifth People's Hospital (Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine), NO.33 Ma Shi Street, Wenjiang District, Chengdu, 611137, China., Li J; Cancer Prevention and Treatment Institute of Chengdu, Department of Thyroid and Breast Surgery, Chengdu Fifth People's Hospital (Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine), NO.33 Ma Shi Street, Wenjiang District, Chengdu, 611137, China. drli_jy@163.com.

المصدر: World journal of surgical oncology [World J Surg Oncol] 2024 Sep 16; Vol. 22 (1), pp. 250. Date of Electronic Publication: 2024 Sep 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819 (Electronic) Linking ISSN: 14777819 NLM ISO Abbreviation: World J Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/pathology , Breast Neoplasms*/mortality , Breast Neoplasms*/drug therapy , Breast Neoplasms*/metabolism , Neoadjuvant Therapy*/methods , Neoadjuvant Therapy*/mortality , Carcinoma, Ductal, Breast*/pathology , Carcinoma, Ductal, Breast*/drug therapy , Carcinoma, Ductal, Breast*/mortality , Carcinoma, Ductal, Breast*/metabolism , Receptor, ErbB-2*/metabolism, Humans ; Female ; Middle Aged ; Survival Rate ; Prognosis ; Follow-Up Studies ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Adult ; Receptors, Progesterone/metabolism ; SEER Program ; Receptors, Estrogen/metabolism ; Aged ; Biomarkers, Tumor/metabolism ; Biomarkers, Tumor/analysis ; Chemotherapy, Adjuvant/methods ; Retrospective Studies

المؤلفون: Bischoff H; Medical Oncology Department, Institut de Cancérologie Strasbourg Europe, ICANS, 17 Rue Albert Calmette, 67033, Strasbourg, France. h.bischoff@icans.eu., Espié M; Medical Oncology Department, Hôpital Saint Louis, Paris, France., Petit T; Medical Oncology Department, Institut de Cancérologie Strasbourg Europe, ICANS, 17 Rue Albert Calmette, 67033, Strasbourg, France.

المصدر: Current treatment options in oncology [Curr Treat Options Oncol] 2024 Sep; Vol. 25 (9), pp. 1210-1224. Date of Electronic Publication: 2024 Aug 15.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100900946 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6277 (Electronic) Linking ISSN: 15346277 NLM ISO Abbreviation: Curr Treat Options Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Neoadjuvant Therapy*/methods , Triple Negative Breast Neoplasms*/therapy , Triple Negative Breast Neoplasms*/drug therapy , Receptor, ErbB-2*/metabolism , Receptor, ErbB-2*/antagonists & inhibitors , Receptors, Estrogen*/metabolism, Humans ; Female ; Biomarkers, Tumor ; Breast Neoplasms/therapy ; Breast Neoplasms/drug therapy ; Breast Neoplasms/metabolism ; Neoplasm Staging ; Disease Management ; Combined Modality Therapy/methods ; Combined Modality Therapy/adverse effects ; Treatment Outcome ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Molecular Targeted Therapy/methods

المؤلفون: Hidaka Y; Department of Epidemiology and Preventive Medicine, Graduate School of Medical and Dental Science, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-8544, Japan.; Department of Digestive Surgery, Graduate School of Medical and Dental Science, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-8544, Japan., Tanoue S; Department of Epidemiology and Preventive Medicine, Graduate School of Medical and Dental Science, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-8544, Japan. tanoue@m.kufm.kagoshima-u.ac.jp., Ayukawa T; Department of Radiology, Graduate School of Medical and Dental Science, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-8544, Japan., Takumi K; Department of Radiology, Graduate School of Medical and Dental Science, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-8544, Japan., Noguchi H; Department of Pathology, Graduate School of Medical and Dental Science, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-8544, Japan., Higashi M; Department of Pathology, Graduate School of Medical and Dental Science, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-8544, Japan., Idichi T; Department of Digestive Surgery, Graduate School of Medical and Dental Science, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-8544, Japan., Kawasaki Y; Department of Digestive Surgery, Graduate School of Medical and Dental Science, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-8544, Japan., Kurahara H; Department of Digestive Surgery, Graduate School of Medical and Dental Science, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-8544, Japan., Mataki Y; Department of Digestive Surgery, Graduate School of Medical and Dental Science, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-8544, Japan., Ohtsuka T; Department of Digestive Surgery, Graduate School of Medical and Dental Science, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-8544, Japan., Koriyama C; Department of Epidemiology and Preventive Medicine, Graduate School of Medical and Dental Science, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-8544, Japan.

المصدر: Journal of gastroenterology [J Gastroenterol] 2024 Sep; Vol. 59 (9), pp. 858-868. Date of Electronic Publication: 2024 Jun 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer International Country of Publication: Japan NLM ID: 9430794 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-5922 (Electronic) Linking ISSN: 09441174 NLM ISO Abbreviation: J Gastroenterol Subsets: MEDLINE

مواضيع طبية MeSH: Pancreatic Neoplasms*/surgery , Pancreatic Neoplasms*/pathology , Neoadjuvant Therapy*/methods , Neoadjuvant Therapy*/adverse effects , Pancreaticoduodenectomy*/adverse effects , Nutritional Status* , Exocrine Pancreatic Insufficiency*/etiology , Pancreatic Ducts*/pathology, Humans ; Male ; Female ; Middle Aged ; Aged ; Retrospective Studies ; Postoperative Complications/epidemiology ; Postoperative Complications/etiology ; Body Composition ; Treatment Outcome

المؤلفون: Mitsui Y; Department of Urology, Toho University Faculty of Medicine, Tokyo, Japan., Okawa M; Department of Urology, Toho University Faculty of Medicine, Tokyo, Japan., Hori S; Department of Urology, Toho University Faculty of Medicine, Tokyo, Japan., Uetani M; Department of Urology, Toho University Faculty of Medicine, Tokyo, Japan., Kasahara M; Department of Urology, Toho University Faculty of Medicine, Tokyo, Japan., Yamabe F; Department of Urology, Toho University Faculty of Medicine, Tokyo, Japan., Kobayashi H; Department of Urology, Toho University Faculty of Medicine, Tokyo, Japan., Nagao K; Department of Urology, Toho University Faculty of Medicine, Tokyo, Japan., Nakajima K; Department of Urology, Toho University Faculty of Medicine, Tokyo, Japan.

المصدر: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2024 Sep; Vol. 31 (9), pp. 1030-1037. Date of Electronic Publication: 2024 May 31.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 9440237 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1442-2042 (Electronic) Linking ISSN: 09198172 NLM ISO Abbreviation: Int J Urol Subsets: MEDLINE

مواضيع طبية MeSH: Urinary Bladder Neoplasms*/drug therapy , Urinary Bladder Neoplasms*/pathology , Urinary Bladder Neoplasms*/mortality , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/administration & dosage , Gemcitabine* , Deoxycytidine*/analogs & derivatives , Deoxycytidine*/administration & dosage , Deoxycytidine*/adverse effects , Neoadjuvant Therapy*/methods , Neoadjuvant Therapy*/adverse effects , Methotrexate*/administration & dosage , Methotrexate*/adverse effects , Cisplatin*/administration & dosage , Cisplatin*/adverse effects , Doxorubicin*/administration & dosage , Doxorubicin*/adverse effects , Vinblastine*/administration & dosage , Vinblastine*/adverse effects , Cystectomy* , Neoplasm Invasiveness*, Humans ; Male ; Female ; Aged ; Middle Aged ; Japan/epidemiology ; Retrospective Studies ; Treatment Outcome ; Progression-Free Survival

المؤلفون: Hayashi M; Department of Surgery, Tochigi Cancer Center, Utsunomiya, Tochigi, Japan., Yoshikawa T; Department of Gastric Surgery, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. tayoshik@ncc.go.jp., Mizusawa J; JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan., Hato S; Department of Gastroenterological Surgery, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan., Iwasaki Y; Department of Surgery, IMS Tokyo Katsushika General Hospital, Tokyo, Japan., Sasako M; Department of Surgery, Yodogawa Christian Hospital, Osaka, Japan., Kawachi Y; Department of Surgery, Nagaoka Chuo General Hospital, Niigata, Japan., Iishi H; Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Japan.; Department of Gastroenterology, Itami City Hospital, Itami, Japan., Choda Y; Department of Surgery, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan., Boku N; Department of Medical Oncology and General Medicine, IMSUT Hospital, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Terashima M; Division of Gastric Surgery, Shizuoka Cancer Center, Shizuoka, Japan.

المصدر: Journal of gastrointestinal cancer [J Gastrointest Cancer] 2024 Sep; Vol. 55 (3), pp. 1125-1133. Date of Electronic Publication: 2024 May 04.

نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 101479627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-6636 (Electronic) NLM ISO Abbreviation: J Gastrointest Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Stomach Neoplasms*/drug therapy , Stomach Neoplasms*/surgery , Stomach Neoplasms*/mortality , Stomach Neoplasms*/complications , Stomach Neoplasms*/pathology , Neoadjuvant Therapy*/methods , Neoadjuvant Therapy*/adverse effects, Humans ; Male ; Female ; Middle Aged ; Prognosis ; Aged ; Postoperative Complications/epidemiology ; Postoperative Complications/etiology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Gastrectomy/adverse effects ; Chemotherapy, Adjuvant/methods ; Chemotherapy, Adjuvant/adverse effects ; Adult

المؤلفون: Miyata H; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Sugimura K; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Kanemura T; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Takeoka T; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Sugase T; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Yasui M; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Nishimura J; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Wada H; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Akita H; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Yamamoto M; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Hara H; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Shinno N; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Omori T; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Yano M; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.

المصدر: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus [Dis Esophagus] 2024 Aug 29; Vol. 37 (9).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 8809160 Publication Model: Print Cited Medium: Internet ISSN: 1442-2050 (Electronic) Linking ISSN: 11208694 NLM ISO Abbreviation: Dis Esophagus Subsets: MEDLINE

مواضيع طبية MeSH: Esophageal Neoplasms*/pathology , Esophageal Neoplasms*/mortality , Esophageal Neoplasms*/therapy , Esophageal Neoplasms*/drug therapy , Neoadjuvant Therapy*/methods , Neoplasm Invasiveness* , Carcinoma, Squamous Cell*/pathology , Carcinoma, Squamous Cell*/therapy , Carcinoma, Squamous Cell*/mortality , Carcinoma, Squamous Cell*/drug therapy , Lymphatic Metastasis* , Esophageal Squamous Cell Carcinoma*/therapy , Esophageal Squamous Cell Carcinoma*/pathology , Esophageal Squamous Cell Carcinoma*/mortality , Esophageal Squamous Cell Carcinoma*/drug therapy , Neoplasm Recurrence, Local*/pathology, Humans ; Male ; Female ; Middle Aged ; Prognosis ; Aged ; Chemotherapy, Adjuvant ; Lymph Nodes/pathology ; Neoplasm Staging ; Retrospective Studies ; Adult ; Esophagectomy ; Multivariate Analysis

المؤلفون: Wu Y; The First Affiliated Hospital of Guangxi University of Science and Technology, Guangxi University of Science and Technology, Liuzhou, Guangxi, China., Huang S; The First Affiliated Hospital of Guangxi University of Science and Technology, Guangxi University of Science and Technology, Liuzhou, Guangxi, China., Wei Y; The First Affiliated Hospital of Guangxi University of Science and Technology, Guangxi University of Science and Technology, Liuzhou, Guangxi, China., Huang M; The First Affiliated Hospital of Guangxi University of Science and Technology, Guangxi University of Science and Technology, Liuzhou, Guangxi, China., Li C; The First Affiliated Hospital of Guangxi University of Science and Technology, Guangxi University of Science and Technology, Liuzhou, Guangxi, China., Liang W; The First Affiliated Hospital of Guangxi University of Science and Technology, Guangxi University of Science and Technology, Liuzhou, Guangxi, China., Qin T; The First Affiliated Hospital of Guangxi University of Science and Technology, Guangxi University of Science and Technology, Liuzhou, Guangxi, China.

المصدر: Frontiers in immunology [Front Immunol] 2024 Aug 23; Vol. 15, pp. 1420214. Date of Electronic Publication: 2024 Aug 23 (Print Publication: 2024).

نوع المنشور: Meta-Analysis; Journal Article; Systematic Review

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/metabolism , Breast Neoplasms*/pathology , Breast Neoplasms*/therapy , Neoadjuvant Therapy*/adverse effects , Neoadjuvant Therapy*/methods , Receptor, ErbB-2*/metabolism, Female ; Humans ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Network Meta-Analysis ; Randomized Controlled Trials as Topic ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/metabolism ; Treatment Outcome

المؤلفون: Yee EK; Department of Surgery, University of Toronto, Toronto, ON M5S 1A1, Canada., Hallet J; Department of Surgery, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.; Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada., Look Hong NJ; Department of Surgery, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.; Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada.; ICES, Toronto, ON M4N 3M5, Canada., Nguyen L; ICES, Toronto, ON M4N 3M5, Canada., Coburn N; Department of Surgery, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.; Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada.; ICES, Toronto, ON M4N 3M5, Canada., Wright FC; Department of Surgery, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.; Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada., Gandhi S; Department of Medicine, University of Toronto, Toronto, ON M5S 1A1, Canada.; Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada., Jerzak KJ; Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada.; Department of Medicine, University of Toronto, Toronto, ON M5S 1A1, Canada.; Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada., Eisen A; Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada.; Department of Medicine, University of Toronto, Toronto, ON M5S 1A1, Canada.; Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada., Roberts A; Department of Surgery, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.; Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada.

المصدر: Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Aug 20; Vol. 31 (8), pp. 4728-4745. Date of Electronic Publication: 2024 Aug 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729 (Electronic) Linking ISSN: 11980052 NLM ISO Abbreviation: Curr Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Neoadjuvant Therapy*/methods , Neoadjuvant Therapy*/statistics & numerical data , Triple Negative Breast Neoplasms*/drug therapy , Referral and Consultation*/statistics & numerical data, Humans ; Female ; Middle Aged ; Retrospective Studies ; Adult ; Aged ; Ontario ; Receptor, ErbB-2/metabolism ; Medical Oncology/statistics & numerical data ; Medical Oncology/methods ; Health Services Accessibility/statistics & numerical data ; Breast Neoplasms/drug therapy ; Cancer Care Facilities/statistics & numerical data

المؤلفون: Qi WX; Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.; Shanghai Key Laboratory of Proton-therapy, Shanghai, 201801, China., Li S; Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.; Shanghai Key Laboratory of Proton-therapy, Shanghai, 201801, China., Li H; Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.; Shanghai Key Laboratory of Proton-therapy, Shanghai, 201801, China., Chen J; Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. cjy11756@rjh.com.cn.; Shanghai Key Laboratory of Proton-therapy, Shanghai, 201801, China. cjy11756@rjh.com.cn., Zhao S; Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. zsg10935@rjh.com.cn.; Shanghai Key Laboratory of Proton-therapy, Shanghai, 201801, China. zsg10935@rjh.com.cn.

المصدر: BMC cancer [BMC Cancer] 2024 Aug 20; Vol. 24 (1), pp. 1029. Date of Electronic Publication: 2024 Aug 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/adverse effects , Neoadjuvant Therapy*/adverse effects , Neoadjuvant Therapy*/methods , Anastomotic Leak*/etiology , Anastomotic Leak*/epidemiology , Esophageal Neoplasms*/therapy , Esophageal Neoplasms*/pathology , Esophageal Squamous Cell Carcinoma*/therapy , Esophageal Squamous Cell Carcinoma*/pathology, Humans ; Male ; Female ; Middle Aged ; Prospective Studies ; Aged ; Nomograms ; Risk Factors ; Retrospective Studies ; Adult ; Chemoradiotherapy/adverse effects ; Chemoradiotherapy/methods ; Antineoplastic Agents, Immunological/therapeutic use ; Antineoplastic Agents, Immunological/adverse effects ; Antineoplastic Agents, Immunological/administration & dosage ; Postoperative Complications/etiology ; Postoperative Complications/epidemiology